Gooch J L, Sandell T V
University of Utah Health Sciences Center, Primary Children's Medical Center, Salt Lake City 84132-0001, USA.
Arch Phys Med Rehabil. 1996 May;77(5):508-11. doi: 10.1016/s0003-9993(96)90042-8.
Botulinum toxin A has been used therapeutically in humans for a variety of conditions since 1980. Over the past few years, it has been used more frequently for spasticity management. We describe the use of botulinum toxin for spasticity or athetosis management in three children with cerebral palsy. Two of these children had severe spasticity or athetosis that was unresponsive to other forms of treatment. The injection of botulinum toxin decreased pain and improved ease of care in these two children. Another child with left hemiparetic cerebral palsy underwent injection of botulinum toxin into upper and lower limb muscles to improve function. In this patient, the injections were combined with other forms of treatment. In this patient spasticity was decreased and function was increased temporarily. The use of botulinum toxin in general is discussed and related to these three cases.
自1980年以来,A型肉毒杆菌毒素已被用于人类治疗多种病症。在过去几年中,它被更频繁地用于治疗痉挛。我们描述了肉毒杆菌毒素在三名脑瘫儿童中用于治疗痉挛或手足徐动症的情况。其中两名儿童患有严重的痉挛或手足徐动症,对其他治疗形式无反应。注射肉毒杆菌毒素减轻了这两名儿童的疼痛并改善了护理的便利性。另一名左半身偏瘫脑瘫儿童接受了肉毒杆菌毒素注射到上肢和下肢肌肉中以改善功能。在该患者中,注射与其他治疗形式相结合。在该患者中,痉挛减轻且功能暂时增强。本文讨论了肉毒杆菌毒素的一般用途并与这三个病例相关联。